Ticker
DERMCompany Name
JOURNEY MEDICAL CORPSector
HealthcareIndustry
Drug Manufacturers - Specialty & GenericExchange
NASDAQDate | Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | EBITDA Margin | Revenues |
---|---|---|---|
6/30/2025 | $ -1.19M | -2.11% | $ 56.4M |
3/31/2025 | $ -1.43M | -2.55% | $ 56.24M |
12/31/2024 | $ -8.4M | -14.96% | $ 56.13M |
9/30/2024 | $ -12.97M | -22.45% | $ 57.77M |
6/30/2024 | $ 5.82M | 7.49% | $ 77.68M |
3/31/2024 | $ 1.26M | 1.57% | $ 80M |
12/31/2023 | $ 1.92M | 2.43% | $ 79.18M |
9/30/2023 | $ -5.69M | -7.12% | $ 79.89M |
6/30/2023 | $ -32.15M | -52.3% | $ 61.47M |
3/31/2023 | $ -31.73M | -50.7% | $ 62.59M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EBITDA / Revenues
(=) EBITDA %
EBITDA % for JOURNEY MEDICAL CORP is calculated as follows: EBITDA [ $ 7.95M ] / Revenues [ $ 44.53M ]
(=) EBITDA % [ 17.85% ]
Minimum
Dec 31, 2021
Maximum
Dec 31, 2020
Average
Median
filtered constituents | 3.29K |
---|---|
min | -75.07% |
max | 97.73% |
average | 16.12% |
median | 14.72% |
std | 26.88% |